Can next-generation antibodies offset biosimilar competition?

被引:31
作者
Mullard, Asher
机构
关键词
D O I
10.1038/nrd3749
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
With the first biosimilar version of a monoclonal antibody now under regulatory review in the European Union, which R&D strategies are innovators relying on to counteract competition?
引用
收藏
页码:426 / 428
页数:3
相关论文
empty
未找到相关数据